First in human study to assess safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
| Author | |
|---|---|
| Abstract |
:
To assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-962212, a first-in-class Factor XIa inhibitor, in Japanese and non-Japanese healthy subjects. |
| Year of Publication |
:
2018
|
| Journal |
:
British journal of clinical pharmacology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0306-5251
|
| URL |
:
http://dx.doi.org/10.1111/bcp.13520
|
| DOI |
:
10.1111/bcp.13520
|
| Short Title |
:
Br J Clin Pharmacol
|
| Download citation |
